CAS 144690-92-6
:Tritylolmesartan medoxomil
Description:
Tritylolmesartan medoxomil is a pharmaceutical compound primarily used as an antihypertensive agent. It is a prodrug of olmesartan, which means it is converted into its active form in the body. The compound features a complex molecular structure that includes a trityl group, enhancing its lipophilicity and bioavailability. Tritylolmesartan medoxomil acts as an angiotensin II receptor blocker (ARB), specifically targeting the AT1 receptor, which plays a crucial role in regulating blood pressure and fluid balance. By inhibiting this receptor, the compound effectively reduces vasoconstriction and promotes vasodilation, leading to lower blood pressure. Its pharmacokinetic properties include good absorption and a relatively long half-life, allowing for once-daily dosing. Additionally, it is characterized by its stability under physiological conditions and its ability to provide sustained antihypertensive effects. As with many medications, potential side effects may include dizziness, headache, or gastrointestinal disturbances, but it is generally well-tolerated in patients.
Formula:C48H44N6O6
InChI:InChI=1S/C48H44N6O6/c1-5-17-41-49-43(47(3,4)57)42(45(55)58-31-40-32(2)59-46(56)60-40)53(41)30-33-26-28-34(29-27-33)38-24-15-16-25-39(38)44-50-51-52-54(44)48(35-18-9-6-10-19-35,36-20-11-7-12-21-36)37-22-13-8-14-23-37/h6-16,18-29,57H,5,17,30-31H2,1-4H3
InChI key:InChIKey=IJOPLMOXIPGJIJ-UHFFFAOYSA-N
SMILES:C(N1C(=NN=N1)C2=C(C=CC=C2)C3=CC=C(CN4C(C(OCC5=C(C)OC(=O)O5)=O)=C(C(C)(C)O)N=C4CCC)C=C3)(C6=CC=CC=C6)(C7=CC=CC=C7)C8=CC=CC=C8
Synonyms:- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
- 1,3-Dioxole, 1H-imidazole-5-carboxylic acid deriv.
- 1H-Imidazole-5-carboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 5-Methoxy-2-oxo-1,3-dioxol-4-yl) methyl-4-(1-hydroxy-1-methylethyl-2 propyl-1-(2-(2-triphenylmethyl)-2H-tetrazole-5-yl) biphenyl-4-yl) methyl)-1H-imidazole-5-carboxylate
- Omst-C
- Trityl Olmesartan Medoximil (N-1)
- Trityl Olmesartan Medoxomil
- Trityl olmesartan
- Tritylolmesartan medoxomil
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
CAS:Formula:C48H44N6O6Purity:98%Color and Shape:SolidMolecular weight:800.8996Tritylolmesartan Medoxomil
CAS:<p>Tritylolmesartan medoxomil is a precursor to olmesartan medoxomil, an AT1 antagonist prodrug.</p>Formula:C48H44N6O6Color and Shape:White To Light Yellow Solid PowderMolecular weight:800.94-(1-Hydroxy-1-methylethyl)-2-propyl-1[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazo-5-carboxylate (5-methyl-2-oxo-1,3-dioxo len-4-yl)methyl
CAS:<p>5-methyl-2-oxo-1,3-dioxo-4-[(4-[2-(trityl)phenyl]phenyl)methylimidazo]-5-carboxylate is a drug that belongs to the group of angiotensin II receptor antagonists. The main human metabolite is the product of N-dealkylation at the nitrogen atom of the imidazole ring. It has been shown to inhibit rat liver microsomes at concentrations of 2.5 and 5 μM. This compound is also found as an impurity in cilexetil and olmesartan, which are other drugs belonging to this class. Impurities can be detected by using metal hydroxides, amines and biphenyl as reagents, or with gas chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry (LC/MS), or high performance liquid chromatography/mass</p>Formula:C48H44N6O6Purity:Min. 95%Color and Shape:SolidMolecular weight:800.9 g/molN1-Trityl Olmesartan Medoxomil
CAS:Formula:C48H44N6O6Color and Shape:White To Off-White SolidMolecular weight:800.92Ref: 4Z-O-0810
Discontinued product




